Picture of WW International logo

WW — WW International News Story

0.000.00%
us flag iconLast trade - 00:00
Consumer DefensivesSpeculativeSmall CapTurnaround

Brief: WW International Q2 Revenue USD 189 Million

Overview

WW fiscal Q2 rev declines 6% yr/yr, Clinical rev grows 55%

Co completes strategic reorganization, reduces debt by $1.15 bln

Predecessor net income margin impacted by reorganization items in fiscal Q2

Outlook

Company projects full-year revenue of $685 mln to $700 mln

WW International expects adjusted EBITDA of $140 mln to $150 mln

Company cites ongoing challenges in behavioral business impacting revenue

Result Drivers

DEBT REDUCTION - Co completed strategic reorganization, reducing debt by $1.15 bln

CLINICAL GROWTH - Clinical revenues rose 55% yr/yr, driven by compounded semaglutide subscriptions

BEHAVIORAL CHALLENGES - Revenue decline attributed to ongoing headwinds in behavioral business

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 Revenue$189 mln
Q2 Net Income$1.19 bln
Press Release: ID:nGNX3mWcLB (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on WW International

See all news